Real World Evidence

**Make your mark for patients**

We are looking for a **Real World Evidence & Outcome Research Strategy Lead **who is creative, innovative and collaborative to join our RWE Immunology team, based in our offices in** Brussels, Belgium, Slough, UK or Monheim, Germany.**

**About the role**

You will be a trusted and integrated leader that shapes & develops robust real-world evidence-based outcome research to facilitate market access strategies. You will create a fit-for-purpose outcome research strategy, based on local, regional and global market access needs, in close alignment with key Asset stakeholder and the RWE Therapeutic area strategy leads. You’ll lead the development of Data/Registry strategies to serve market access purposes and guides the design, development and implementation of outcome research projects based on RWE methodologies, which address the prioritized research questions.

**Who you’ll work with**

The RWE Immunology team is responsible for developing compelling evidence demonstrating the clinical, humanistic, and economic value of UCB’s medicines to payers, prescribers, patients, and aligned healthcare decision makers, serving regulatory, medical and market access purposes.

**What you’ll do**
- Create a strategic outcome research plan to confirm and show the value of Bimekizumab, as a basis for and supporting market access activities on global, regional and local basis.
- Gap analysis and data strategy related to unmet needs and opportunities to improve standard of care, economic value, drug utilization, cost-effectiveness and comparative effectiveness including long term and patient centric outcomes.
- Execution and support of execution of solis outcome research studies on time and to budget; including identifying required resources, meeting scientific quality expectations and governance requirements.
- Cross-functional collaboration to ensure seamless ways of working on Asset sub-teams; Payer HE&OR sub-team; Patient Impact regional and local teams related to market access evidence needs.
- Cultivate and maintain relationships with key external experts, influencers and customer segments to foster and maintain UCB’s credibility in RWE quality and relevance.

**Interested? For this role we’re looking for the following education, experience and skills**
- Educated at least to MD, PharmD or graduate level in epidemiology or life sciences.
- Minimum 5 years of experience in designing and executing Outcome research
- Understanding market access thinking and being able to translate market access needs into solid research questions
- Experience successfully conceptualizing and delivering RWE and in particular Outcome research projects using primary or secondary data
- Track record of project leadership in pharma or CRO setting

If you are interested to learn more about R&D within UCB, please find more information here R&D at UCB.

RANDATUCB

Are you ready to ‘go beyond’ to create value and make your mark for patients? If this sounds like you, then we would love to hear from you

**About us**
UCB is a global biopharmaceutical company, focusing on neurology and immunology. We are around 8,500 people in all four corners of the globe, inspired by patients and driven by science.

**Why work with us?**
At UCB, we don’t just complete tasks, we create value. We aren’t afraid to push forward, collaborate, and innovate to make our mark for patients. We have a caring, supportive culture where everyone feels included, respected, and has equitable opportunities to do their best work. We ‘go beyond’ to create value for our patients, and always with a human focus, whether that’s on our patients, our employees, or our planet. Working for us, you will discover a place where you can grow, and have the freedom to carve your own career path to achieve your full potential.

UCB and its subsidiaries encourage diversity and inclusion in the workplace; we are an Equal Opportunity Employer. We do not discriminate on the basis of race/color/religion/sex/national origin/veteran/disability/age/sexual orientation/gender identity.